Creating policy frameworks for public health genomics to benefit developing countries

Personalized Medicine
Tikki Pang, Mikkel Oestergaard

Abstract

Unprecedented advances in life sciences, as exemplified by the revolution in genomics, are yet to translate into effective public health interventions to benefit the health of populations living in the developing world. The developing countries continue to bear the major burden of disease globally, both infectious and chronic diseases, and they could clearly benefit from genomics being harnessed and used to address the greatest public health problems in addition to benefits for the health of individuals. For this to happen, we need to understand what are the major challenges or bottlenecks to be overcome and, informed by these priorities, create an effective, inclusive, equitable and sustainable policy framework within which knowledge translation into improved health outcomes of underprivileged populations can take place.

References

Oct 2, 2002·Nature Genetics·Abdallah S DaarPeter A Singer
Apr 16, 2003·Nature·Francis S CollinsUNKNOWN US National Human Genome Research Institute
Oct 18, 2003·Science·H VarmusP A Singer
Nov 23, 2007·Nature·Abdallah S DaarJohn Bell
Dec 17, 2008·Nature·UNKNOWN Malaria Genomic Epidemiology Network
Apr 17, 2010·Public Health Genomics·Peter O'Leary, R L Zimmern
Apr 17, 2010·Public Health Genomics·Bartha Maria KnoppersD Avard
Oct 15, 2010·The New England Journal of Medicine·Charles N Rotimi, Lynn B Jorde
Feb 11, 2011·Nature·Eric D GreenUNKNOWN National Human Genome Research Institute
Feb 19, 2011·Science·James P EvansTimothy Caulfield
Jul 8, 2011·Nature·Pamela Y CollinsDan J Stein
Jul 29, 2011·The New England Journal of Medicine·David A Relman
Nov 19, 2011·Genetic Testing and Molecular Biomarkers·Elizabeth J HornSharon F Terry
Nov 19, 2011·American Journal of Public Health·Muin J KhouryW David Dotson
Nov 30, 2011·Lancet·Zara Qadir
Mar 30, 2012·The New England Journal of Medicine·Fasil Tekola AyeleGail Davey
May 23, 2012·Lancet·Tikki Pang, David Weatherall

❮ Previous
Next ❯

Citations

May 19, 2019·European Journal of Human Genetics : EJHG·Moeen RiazPaul Lacaze

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.